This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Cellular Dynamics International, Inc., Fujifilm Cellular Dynamics, Inc.. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016-2019
Title: Randy Learish: Innovator in Induced Pluripotent Stem Cell Research
Introduction
Randy Learish is a notable inventor based in Oregon, WI (US). He has made significant contributions to the field of stem cell research, particularly in the area of induced pluripotent stem cells (iPS cells). With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Randy Learish's latest patents focus on reprogramming T cells and hematopoietic cells. The methods and compositions he developed relate to the production of induced pluripotent stem cells. For instance, these iPS cells can be generated from CD34 hematopoietic cells, such as human CD34 blood progenitor cells or T cells. His inventions also provide various iPS cell lines and novel induced pluripotent stem cells with a genome that includes genetic rearrangement of T cell receptors.
Career Highlights
Throughout his career, Randy has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Fujifilm Cellular Dynamics, Inc. and Cellular Dynamics International, Inc. His experience in these organizations has contributed to his expertise in stem cell technology and innovation.
Collaborations
Randy has collaborated with several professionals in his field, including Matthew Brown and Elizabeth Rondon Dominguez. These partnerships have likely enhanced his research and development efforts in stem cell applications.
Conclusion
Randy Learish is a distinguished inventor whose work in induced pluripotent stem cells showcases his innovative spirit and dedication to advancing medical science. His contributions are paving the way for future breakthroughs in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile